DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
Qdolo is a drug marketed by Athena and is included in one NDA.
The generic ingredient in QDOLO is tramadol hydrochloride. There are thirty-six drug master file entries for this compound. Forty-two suppliers are listed for this compound. Additional details are available on the tramadol hydrochloride profile page.
A generic version of QDOLO was approved as tramadol hydrochloride by SUN PHARM INDS INC on June 19th, 2002.
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||TE||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
|Athena||QDOLO||tramadol hydrochloride||SOLUTION;ORAL||214044-001||Sep 1, 2020||RX||Yes||Yes||⤷ Free Forever Trial||⤷ Free Forever Trial||⤷ Free Forever Trial|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>TE||>Type||>RLD||>RS||>Patent No.||>Patent Expiration||>Product||>Substance||>Delist Req.||>Exclusivity Expiration|